A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...
For patients with Crohn's disease or ulcerative colitis who have exhausted other treatment options, a new combination therapy ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. I think the most important thing when you ...
Hosted on MSN
Living well with Crohn’s and colitis
Crohn’s disease and ulcerative colitis, the two main types of inflammatory bowel disease (IBD), affect millions and can bring ...
A new fixed-dose co-antibody therapy appears to be effective for managing ulcerative colitis and Crohn disease.
For too long you have suffered from inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS). Crohn’s disease.
Specific protein signatures can predict Crohn's disease and ulcerative colitis, enabling early intervention in IBD. The study identified 34 proteins for Crohn's disease and 45 for ulcerative colitis, ...
Picture this common clinical scenario: A patient has chronic diarrhea, abdominal pain, and weight loss. Blood and stool tests point to inflammatory bowel disease (IBD). But which one -- Crohn's ...
(RTTNews) - AbbVie (ABBV) Monday announced the U.S. Food and Drug Administration (FDA) approval of a supplemental new drug application (sNDA) that updates the indication statement for RINVOQ ...
Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD). It causes painful sores and inflammation deep inside your colon and rectum. That can lead to hard-to-manage symptoms like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results